BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 10338044)

  • 1. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
    Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
    Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal.
    Pope B; Brown R; Gibson J; Joshua D
    Bone Marrow Transplant; 1997 Aug; 20(3):205-10. PubMed ID: 9257888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.
    Ross AA; Miller GW; Moss TJ; Kahn DG; Warner NE; Sweet DL; Louie KG; Schneidermann E; Pecora AL; Meagher RC
    Bone Marrow Transplant; 1995 Jun; 15(6):929-33. PubMed ID: 7581093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
    Kimlinger T; Witzig TE
    Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of tumor contamination in peripheral blood stem cell harvests.
    Craig JI; Langlands K; Parker AC; Anthony RS
    Exp Hematol; 1994 Aug; 22(9):898-902. PubMed ID: 7914873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique.
    Orfäo A; García-Sanz R; López-Berges MC; Belén Vidriales M; González M; Caballero MD; San Miguel JF
    Cytometry; 1994 Dec; 17(4):332-9. PubMed ID: 7533074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support.
    Boccadoro M; Omedé P; Dominietto A; Palumbo A; Bringhen S; Giaretta F; Ortolano B; Triolo S; Pileri A
    Bone Marrow Transplant; 2000 Jan; 25(1):25-9. PubMed ID: 10654010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts.
    Vescio RA; Han EJ; Schiller GJ; Lee JC; Wu CH; Cao J; Shin J; Kim A; Lichtenstein AK; Berenson JR
    Bone Marrow Transplant; 1996 Jul; 18(1):103-10. PubMed ID: 8832002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic analysis of peripheral blood stem cell harvests from patients with multiple myeloma.
    Mateo G; Corral M; Almeida J; López-Berges C; Nieto mJ; García-Marcos A; Vázquez L; del Cañizo C; Orfao A; San Miguel JF
    Haematologica; 2003 Sep; 88(9):1013-21. PubMed ID: 12969809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric determination of ploidy and proliferative activity on isolated bone marrow particles and on total bone marrow aspirate.
    Ucci G; Mazzini G; Caporali R; Danova M; Montecucco CM; Riccardi A
    Basic Appl Histochem; 1987; 31(1):83-90. PubMed ID: 3593175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloma cell contamination of peripheral blood stem cell grafts in patients with multiple myeloma treated by high-dose therapy.
    Mariette X; Fermand JP; Brouet JC
    Bone Marrow Transplant; 1994 Jul; 14(1):47-50. PubMed ID: 7524906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation.
    Lipinski E; Cremer FW; Ho AD; Goldschmidt H; Moos M
    Bone Marrow Transplant; 2001 Nov; 28(10):957-62. PubMed ID: 11753551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA content analysis of peripheral blood B-lymphocytes in plasma cell malignancies.
    Montecucco C; Riccardi A; Mazzini G; Danova M; Ucci G; Giordano PA
    Basic Appl Histochem; 1985; 29(3):275-82. PubMed ID: 3877500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric immunophenotyping and minimal residual disease analysis in multiple myeloma.
    Gupta R; Bhaskar A; Kumar L; Sharma A; Jain P
    Am J Clin Pathol; 2009 Nov; 132(5):728-32. PubMed ID: 19846814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O; Heider U; Zavrski I; Possinger K
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.